Akoya Biosciences (AKYA)

Akoya Biosciences Stock Analysis & Ratings

AKYA Stock Chart & Stats

Day’s Range$9.41 - $10.19
52-Week Range$8.02 - $23.44
Previous Close$9.4
Average Volume (3M)65.84K
Market Cap$373.26M
P/E Ratio-7.2
Next EarningsAug 09, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score3
EPS (TTM)-1.39



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Akoya Biosciences’s price range in the past 12 months?
Akoya Biosciences lowest stock price was $8.02 and its highest was $23.44 in the past 12 months.
    What is Akoya Biosciences’s market cap?
    Akoya Biosciences’s market cap is $373.26M.
      What is Akoya Biosciences’s price target?
      The average price target for Akoya Biosciences is $18.67. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $20.00 ,the lowest forecast is $18.00. The average price target represents 88.02% Increase from the current price of $9.93.
        What do analysts say about Akoya Biosciences?
        Akoya Biosciences’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Akoya Biosciences’s upcoming earnings report date?
          Akoya Biosciences’s upcoming earnings report date is Aug 09, 2022 which is in 85 days.
            How were Akoya Biosciences’s earnings last quarter?
            Akoya Biosciences released its earnings results on May 05, 2022. The company reported -$0.438 earnings per share for the quarter, missing the consensus estimate of -$0.388 by -$0.05.
              Is Akoya Biosciences overvalued?
              According to Wall Street analysts Akoya Biosciences’s price is currently Undervalued.
                Does Akoya Biosciences pay dividends?
                Akoya Biosciences does not currently pay dividends.
                What is Akoya Biosciences’s EPS estimate?
                Akoya Biosciences’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Akoya Biosciences have?
                Akoya Biosciences has 37,590,000 shares outstanding.
                  What happened to Akoya Biosciences’s price movement after its last earnings report?
                  Akoya Biosciences reported an EPS of -$0.438 in its last earnings report, missing expectations of -$0.388. Following the earnings report the stock price went down -4.138%.
                    Which hedge fund is a major shareholder of Akoya Biosciences?
                    Among the largest hedge funds holding Akoya Biosciences’s share is Hudson Executive Capital Lp. It holds Akoya Biosciences’s shares valued at 37M.


                      Akoya Biosciences Stock Analysis

                      Smart Score
                      Price Target
                      ▲(88.02% Upside)
                      Strong Buy
                      The Akoya Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Akoya Biosciences

                      Akoya Biosciences Inc is an an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. It offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications.

                      Similar Stocks
                      No data currently available

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis